• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初级保健在心肿瘤学中的重要性。

The Importance of Primary Care in Cardio-Oncology.

机构信息

GenesisCare Cardiology, GenesisCare, Building 1 & 11, The Mill, 41-43 Bourke Road, Alexandria, Sydney, NSW, 2015, Australia.

Discipline of Medicine, School of Medicine, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, 5000, Australia.

出版信息

Curr Treat Options Oncol. 2021 Oct 21;22(12):107. doi: 10.1007/s11864-021-00908-2.

DOI:10.1007/s11864-021-00908-2
PMID:34674055
Abstract

There is significant interplay between cancer and cardiovascular disease involving shared risk factors, cross disease communication where cardiovascular events can influence cancer recurrence, and mortality rates and cardiotoxicity from cancer treatments with resultant increased cardiovascular mortality and morbidity in cancer patients. This is a major cause of death in many long-term cancer survivors. As a result, cardio-oncology, which involves the prevention, early detection, and optimal treatment of cardiovascular disease in patients treated for cancer, is expanding globally. However, there is still limited awareness of its importance and limited application of the lessons already learnt. Primary care physicians, and their clinical teams, especially nursing colleagues, have a foundation role in the management of all patients, and this paper outlines areas where they can lead in the cardio-oncology management of cancer patients. Although there is currently a lack of an adequate clinical framework or shared care plan, primary care physicians have a role to play in the various phases of cancer treatment: pre-therapy, during therapy, and survivorship.

摘要

癌症和心血管疾病之间存在着显著的相互作用,涉及共同的风险因素、交叉疾病的交流,心血管事件会影响癌症的复发和死亡率,以及癌症治疗的心脏毒性,导致癌症患者的心血管死亡率和发病率增加。这是许多长期癌症幸存者的主要死亡原因。因此,全球范围内的肿瘤心脏病学正在不断发展,其涉及预防、早期发现和癌症治疗患者心血管疾病的最佳治疗。然而,人们对其重要性的认识仍然有限,已经学到的经验教训的应用也有限。初级保健医生及其临床团队,尤其是护理同事,在所有患者的管理中都发挥着基础作用,本文概述了他们在癌症患者的肿瘤心脏病学管理中可以发挥主导作用的领域。尽管目前缺乏足够的临床框架或共同护理计划,但初级保健医生在癌症治疗的各个阶段都有作用:治疗前、治疗期间和生存期间。

相似文献

1
The Importance of Primary Care in Cardio-Oncology.初级保健在心肿瘤学中的重要性。
Curr Treat Options Oncol. 2021 Oct 21;22(12):107. doi: 10.1007/s11864-021-00908-2.
2
The Cardio-oncology Program: A Multidisciplinary Approach to the Care of Cancer Patients With Cardiovascular Disease.肿瘤心脏病学计划:心血管疾病癌症患者护理的多学科方法。
Can J Cardiol. 2016 Jul;32(7):847-51. doi: 10.1016/j.cjca.2016.04.014. Epub 2016 May 6.
3
[Heart and cancer: cardio-oncology].[心脏与癌症:心血管肿瘤学]
Herz. 2024 Mar;49(2):111-117. doi: 10.1007/s00059-024-05232-7. Epub 2024 Jan 30.
4
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next Level.癌症患者及癌症幸存者的心血管健康:迈向新高度的路线图。
J Am Coll Cardiol. 2015 Jun 30;65(25):2739-46. doi: 10.1016/j.jacc.2015.04.059.
5
Insights into cardio-oncology: the patient's heavy cancer journey among doubts, controversies and pitfalls. The role of the cardiologist.心血管肿瘤学洞察:患者在疑虑、争议和陷阱中的艰难抗癌历程。心脏病专家的作用。
Int J Cardiol. 2015 Jan 15;178:175-7. doi: 10.1016/j.ijcard.2014.10.167. Epub 2014 Oct 28.
6
The Role of Nursing in the Delivery of Cardio-Oncology.护理在心脏肿瘤学中的作用。
Curr Treat Options Oncol. 2024 Oct;25(10):1268-1275. doi: 10.1007/s11864-024-01241-0. Epub 2024 Sep 17.
7
Cardio-oncology: an ongoing evolution.心脏肿瘤学:不断发展
Future Oncol. 2015;11(14):2059-66. doi: 10.2217/fon.15.89.
8
Rationale for Cardio-Oncology Units.心脏肿瘤学科室的基本原理。
Rev Esp Cardiol (Engl Ed). 2017 Jul;70(7):583-589. doi: 10.1016/j.rec.2017.02.006. Epub 2017 Mar 16.
9
Cardio-Oncology for the Primary Care Provider.心血管肿瘤学:初级保健提供者实用指南。
Rom J Intern Med. 2023 May 30;61(3):127-134. doi: 10.2478/rjim-2023-0012. Print 2023 Sep 1.
10
Cardio-Oncology - A new subspecialty with collaboration at its heart.心脏肿瘤学——一门以合作为核心的新兴亚专业。
Indian Heart J. 2017 Jul-Aug;69(4):556-562. doi: 10.1016/j.ihj.2017.05.006. Epub 2017 May 27.

引用本文的文献

1
Cardiac function surveillance practices and outcomes in patients with HER2-positive breast cancer treated with trastuzumab: a retrospective cohort study across a safety-net and tertiary care setting.曲妥珠单抗治疗的HER2阳性乳腺癌患者的心脏功能监测实践及结果:一项跨越安全网和三级医疗机构的回顾性队列研究
Cardiooncology. 2025 Aug 21;11(1):74. doi: 10.1186/s40959-025-00376-9.
2
Prevalence of Australians exposed to potentially cardiotoxic cancer medicines: a population-based cohort study.接触潜在心脏毒性癌症药物的澳大利亚人的患病率:一项基于人群的队列研究。
Lancet Reg Health West Pac. 2023 Aug 2;39:100872. doi: 10.1016/j.lanwpc.2023.100872. eCollection 2023 Oct.
3

本文引用的文献

1
Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer.癌症病史患者心脏保护药物的使用未达最佳状态。
JACC CardioOncol. 2020 Jun 16;2(2):312-315. doi: 10.1016/j.jaccao.2020.05.010. eCollection 2020 Jun.
2
Addressing Cardiovascular Risk of Prostate Cancer Hormonal Therapy.应对前列腺癌激素治疗的心血管风险
JACC CardioOncol. 2020 Mar 17;2(1):82-83. doi: 10.1016/j.jaccao.2020.02.002. eCollection 2020 Mar.
3
Anthracycline-Induced Cardiotoxicity: Remembering the Forgotten Ventricle.蒽环类药物所致心脏毒性:铭记被遗忘的心室。
Cardio-oncology for Pediatric and Adolescent/Young Adult Patients.
儿科和青少年/青年成人患者的心脏肿瘤学。
Curr Treat Options Oncol. 2023 Aug;24(8):1052-1070. doi: 10.1007/s11864-023-01100-4. Epub 2023 Jun 10.
JACC CardioOncol. 2020 Mar 17;2(1):23-25. doi: 10.1016/j.jaccao.2020.02.012. eCollection 2020 Mar.
4
Cardiovascular Toxicities of Androgen Deprivation Therapy.雄激素剥夺治疗的心血管毒性。
Curr Treat Options Oncol. 2021 Apr 17;22(6):47. doi: 10.1007/s11864-021-00846-z.
5
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
6
Late mortality in people with cancer: a population-based Australian study.癌症患者的晚期死亡率:一项基于人群的澳大利亚研究。
Med J Aust. 2021 Apr;214(7):318-323. doi: 10.5694/mja2.50879. Epub 2020 Dec 9.
7
Real-world experience of carfilzomib-associated cardiovascular adverse events: SEER-Medicare data set analysis.卡非佐米相关心血管不良事件的真实世界经验:SEER-医疗保险数据集分析。
Cancer Med. 2021 Jan;10(1):70-78. doi: 10.1002/cam4.3568. Epub 2020 Nov 10.
8
Reporting incidental coronary, aortic valve and cardiac calcification on non-gated thoracic computed tomography, a consensus statement from the BSCI/BSCCT and BSTI.非门控胸部 CT 报告偶然发现的冠状动脉、主动脉瓣和心脏钙化:BSCI/BSCCT 和 BSTI 的共识声明。
Br J Radiol. 2021 Jan 1;94(1117):20200894. doi: 10.1259/bjr.20200894. Epub 2020 Oct 29.
9
Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study.诊断时年龄在 50 至 59 岁的乳腺癌幸存者中标准低剂量蒽环类化疗对晚期充血性心力衰竭的影响:一项全国性研究。
Breast. 2020 Oct;53:125-129. doi: 10.1016/j.breast.2020.07.006. Epub 2020 Jul 31.
10
Coronary artery calcium scoring in cardiovascular risk assessment of people with family histories of early onset coronary artery disease.家族性早发冠心病患者心血管风险评估中的冠状动脉钙评分。
Med J Aust. 2020 Aug;213(4):170-177. doi: 10.5694/mja2.50702. Epub 2020 Jul 30.